Fintel reports that on September 23, 2025, Guggenheim upgraded their outlook for Genmab A (NasdaqGS:GMAB) from Neutral to Buy.
Analyst Price Forecast Suggests 127.83% Upside
As of September 13, 2025, the average one-year price target for Genmab A is $65.47/share. The forecasts range from a low of -$95.76 to a high of $219.90. The average price target represents an increase of 127.83% from its latest reported closing price of $28.74 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Genmab A is 22,486MM, an increase of 516.58%. The projected annual non-GAAP EPS is 126.42.
What is the Fund Sentiment?
There are 263 funds or institutions reporting positions in Genmab A. This is an decrease of 7 owner(s) or 2.59% in the last quarter. Average portfolio weight of all funds dedicated to GMAB is 0.11%, an increase of 13.04%. Total shares owned by institutions decreased in the last three months by 5.22% to 72,978K shares. 
The put/call ratio of GMAB is 0.34, indicating a bullish outlook.
What are Other Shareholders Doing?
Alliancebernstein holds 10,662K shares. In its prior filing, the firm reported owning 14,725K shares , representing a decrease of 38.10%. The firm decreased its portfolio allocation in GMAB by 43.01% over the last quarter.
Orbis Allan Gray holds 7,920K shares. In its prior filing, the firm reported owning 5,711K shares , representing an increase of 27.90%. The firm decreased its portfolio allocation in GMAB by 17.03% over the last quarter.
APGAX - AB LARGE CAP GROWTH FUND INC holds 4,102K shares. In its prior filing, the firm reported owning 4,310K shares , representing a decrease of 5.06%. The firm increased its portfolio allocation in GMAB by 18.46% over the last quarter.
Citadel Advisors holds 3,569K shares. In its prior filing, the firm reported owning 4,427K shares , representing a decrease of 24.02%. The firm decreased its portfolio allocation in GMAB by 31.15% over the last quarter.
Arrowstreet Capital, Limited Partnership holds 3,454K shares. In its prior filing, the firm reported owning 1,369K shares , representing an increase of 60.36%. The firm increased its portfolio allocation in GMAB by 131.80% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
